MarketInOut Stock Screener Log In | Sign Up
 

Avicanna Inc

TSX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 06/05/2026
Avicanna Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSX
Market Capitalization15.72 mln
Float104 mln
Earnings Date08/12/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.39
Borderline

Relative Strength

7 / 100
Severely lagging

Debt / Equity

0.01
Debt-free

ROE

-104
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

Avicanna is a Canadian biopharmaceutical company focused on developing and selling cannabis-based products for consumer, medical, and pharmaceutical use across Canada and global markets. Its product range spans topical creams, oral drops, and transdermal formats sold under the RHO Phyto brand, alongside targeted treatments for conditions such as chronic pain, skin disorders, and epilepsy. The company also grows and supplies raw cannabinoid ingredients under the Aureus Santa Marta brand and runs MyMedi.ca, a bilingual online platform where patients receive pharmacist support and access to a broad selection of medical cannabis products. Founded in 2016 and based in Toronto, Avicanna works with private and public insurers to support patient reimbursement and partners with a European pharmaceutical firm to advance its proprietary drug delivery technology.

Key Fundamentals

EPS-0.02
ROE-104
RPS0.22
ROIC-23.02
ROA-15.17
EBITDA, mln-2.37
EV / EBITDA-10.58
EV / EBIT-8.13
Revenue, mln25.83
EV / Revenue0.97

Financial Strength

Altman Z-Score-4.96
Piotroski F-Score 5 / 9
Beneish M-Score-2.39
Short Ratio0.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8% 16 / 100   
1 Month -17.86% 7 / 100   
2 Months -34.29% 4 / 100   
6 Months -54% 2 / 100   
1 Year -57.41% 2 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us